Skip to content
Tenfell
Closed tender
Published 24 Nov 2022

(NU/1824) The Provision of Clinical Research Support & Central Laboratory Services for the ADVANCE Study

NEWCASTLE UNIVERSITY · United Kingdom

Key facts

Estimated value
£2,200,000
Closing date
05 Jan 2023
Contract starts
06 Feb 2023
Contract ends
15 Feb 2028
Procedure
Open procedure
Buyer type
Education

Description

The Newcastle University Translational and Clinical Research Institute is one of three research institutes established in 2019 following a restructure within the Faculty of Medical Sciences. Its members map across the biomedical research landscape. A number of major research projects are led from within the Institute including the "NASH Disease Translational Accelerator" (NASH-DTA) project. This project funded brings together clinicians and scientists from prominent academic centres across Europe and industrial partners to conduct research into advanced liver disease/cirrhosis caused by non-alcoholic fatty liver disease (NAFLD). Their common goals are developing, validating and qualifying better biomarkers for NAFLD. Strongly associated with the epidemics of obesity and type 2 diabetes that are testing healthcare systems worldwide, NAFLD is an increasingly common cause of advanced liver disease that is characterized by substantial inter-patient variability in severity and rate of progression. Biomarkers under investigation in the project include genes that contribute to NAFLD progression.

The purpose of this tender process is to engage a supplier to provide clinical research support, central laboratory services and to oversee biological sample transfers and provide centralised laboratory processing of biological samples collected during the course of the study.

Categories (CPV)

Similar open tenders

About NEWCASTLE UNIVERSITY

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.